Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · IEX Real-Time Price · USD
15.13
-0.21 (-1.37%)
At close: Apr 19, 2024, 4:00 PM
15.17
+0.04 (0.26%)
After-hours: Apr 19, 2024, 7:59 PM EDT

Catalyst Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2004
Revenue
398.2214.2140.83119.07102.310.50000
Upgrade
Revenue Growth (YoY)
85.90%52.10%18.27%16.39%20361.20%-----
Upgrade
Cost of Revenue
51.9734.3921.8817.0414.7600000
Upgrade
Gross Profit
346.24179.81118.95102.0387.550.50000
Upgrade
Selling, General & Admin
133.7157.0949.6344.2336.8815.887.37.918.64.47
Upgrade
Research & Development
93.1519.7916.9416.518.8419.9211.3811.3711.810.12
Upgrade
Other Operating Expenses
32.571.100000000
Upgrade
Operating Expenses
259.4377.9766.5660.7355.7235.818.6819.2820.414.59
Upgrade
Operating Income
86.81101.8452.3941.331.82-35.3-18.68-19.28-20.4-14.59
Upgrade
Other Expense / Income
-7.7-2.88-0.28-0.59-1.59-1.29-0.27-1.21-0.170.92
Upgrade
Pretax Income
94.51104.7252.6741.8933.41-34-18.41-18.07-20.23-15.51
Upgrade
Income Tax
23.121.6413.19-33.091.5300000
Upgrade
Net Income
71.4183.0839.4874.9831.88-34-18.41-18.07-20.23-15.51
Upgrade
Net Income Growth
-14.05%110.42%-47.35%135.24%------
Upgrade
Shares Outstanding (Basic)
10610310310410310386838164
Upgrade
Shares Outstanding (Diluted)
11411110810610610386838164
Upgrade
Shares Change
2.13%3.32%1.46%0.21%3.30%19.62%3.53%2.49%26.06%41.12%
Upgrade
EPS (Basic)
0.670.800.380.720.31-0.33-0.21-0.22-0.25-0.24
Upgrade
EPS (Diluted)
0.630.750.370.710.30-0.33-0.21-0.22-0.25-0.24
Upgrade
EPS Growth
-16.00%102.70%-47.89%136.67%------
Upgrade
Free Cash Flow
143.37116.0259.3545.0234.59-26.24-13.74-18.06-18.04-13
Upgrade
Free Cash Flow Per Share
1.351.120.570.430.34-0.26-0.16-0.22-0.22-0.20
Upgrade
Gross Margin
86.95%83.94%84.46%85.69%85.57%100.00%----
Upgrade
Operating Margin
21.80%47.54%37.20%34.69%31.11%-7059.03%----
Upgrade
Profit Margin
17.93%38.79%28.03%62.97%31.16%-6800.70%----
Upgrade
Free Cash Flow Margin
36.00%54.16%42.14%37.81%33.81%-5247.91%----
Upgrade
Effective Tax Rate
24.44%20.66%25.03%-79.00%4.59%-----
Upgrade
EBITDA
127.65106.2153.1542.7833.71-33.97-18.37-18.03-20.2-15.48
Upgrade
EBITDA Margin
32.06%49.58%37.74%35.92%32.95%-6793.11%----
Upgrade
Depreciation & Amortization
33.141.490.480.890.30.040.050.040.030.03
Upgrade
EBIT
94.51104.7252.6741.8933.41-34-18.41-18.07-20.23-15.51
Upgrade
EBIT Margin
23.73%48.89%37.40%35.18%32.66%-6800.70%----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).